Global Antibody Market Growth 2025-2031

Global Antibody Market Growth 2025-2031

The global Antibody market size is predicted to grow from US$ 9853 million in 2025 to US$ 13580 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.

In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.

LP Information, Inc. (LPI) ' newest research report, the “Antibody Industry Forecast” looks at past sales and reviews total world Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibody sales for 2025 through 2031. With Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody industry.

This Insight Report provides a comprehensive analysis of the global Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibody market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
IgM
IgG
IgA
Other

Segmentation by Application:
Therapeutic
Research
Diagnostic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antibody market?

What factors are driving Antibody market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antibody market opportunities vary by end market size?

How does Antibody break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.